Grifols (CHIX:GRFPE) Other Long Term Assets : €509 Mil (As of Dec. 2024)

View and export this data going back to 2012. Start your Free Trial

What is Grifols Other Long Term Assets?

Grifols's other long-term assets for the quarter that ended in Dec. 2024 was €509 Mil.

Grifols's quarterly other long-term assets declined from Jun. 2024 (€619 Mil) to Sep. 2024 (€453 Mil) but then increased from Sep. 2024 (€453 Mil) to Dec. 2024 (€509 Mil).

Grifols's annual other long-term assets increased from Dec. 2022 (€299 Mil) to Dec. 2023 (€583 Mil) but then declined from Dec. 2023 (€583 Mil) to Dec. 2024 (€509 Mil).

Grifols Other Long Term Assets Historical Data

The historical data trend for Grifols's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Grifols Other Long Term Assets Chart

Grifols Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Long Term Assets

Get a 7-Day Free Trial

237.04

251.44

299.11

582.50

509.39

Grifols Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Dec21	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23	Jun24	Sep24	Dec24
Other Long Term Assets	Get a 7-Day Free Trial															296.95	582.50	619.07	453.49	509.39

Grifols Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Grifols Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Grifols SA (CHIX:GRFPe) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

GIKLY:USA GIFLF:USA GRFS:USA 1GRF:Italy GRFe:UK 0RDV:UK 0RDU:UK GRF.P:Spain GRF:Spain G0F0:Germany GRF:Austria

Address

Avinguda de la Generalitat, 152-158, Parc de Negocis Can Sant Joan, Sant Cugat del Valles, Barcelona, ESP, 08174

Website

https://www.grifols.com

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

Grifols Headlines

No Headlines